“I think a lot of innovation comes from smaller companies, this will be an even bigger trend in the future,” says Fibrocell CEO Pernock, whose own company is focused on treatments for skin diseases and conditions.
Each year during November, the Movember Foundation is responsible for the sprouting of moustaches on thousands of men’s faces around the world. The aim is to raise vital funds and awareness for men’s health, specifically prostate cancer and testicular cancer. JC, Australian founder of Movember sounds the gong in Amsterdam.
Once registered at movember.com each Mo Bro must begin the 1st of Movember with a clean shaven face. For the entire month, each Mo Bro must grow and groom a moustache. Mo Bros effectively become walking, talking billboards for the 30 days of November and through their actions and words raise awareness by prompting private and public conversation around the often ignored issue of men’s health. NYSE Euronext is proud to continue to support these...
Every day, from now until the end of 2012, Médecins Sans Frontières (MSF) will publish short news bulletins from its aid projects on news tickers throughout the Netherlands.
With this campaign the medical emergency aid organisation aims to highlight the importance of emergency aid. Delegate director Katrien Coppens, who sounds the gong today, says: "Day after day our teams provide assistance to people in need, from the victims of fighting and bombing, to people suffering from malaria who need medicines desperately. We want to draw attention to their distress as the plight of these people often goes unnoticed by the outside world." You can read Médecins Sans Frontières' news tickers until the end of 2012 on railway stations, TV and via Uitzending Gemist.
On Friday, October 26, executives and guests of Summit Midstream Partners, a growth-oriented master limited partnership focused on owning and operating midstream energy infrastructure, will visit the New York Stock Exchange (NYSE) to celebrate the company's recent initial public offering and listing on the NYSE. Summit Midstream Partners began trading on the NYSE on September 28, 2012 under the ticker symbol "SMLP."
Laurent Levy, CEO of Nanobiotix, opens the European trading day in Paris.
Nanobiotix develops nanoparticle-based technologies used in safe and non-invasive cancer treatments. Nanobiotix’s technology, NanoXray, seeks to improve the efficacy of radiation therapy by limiting healthy tissues’ tolerance to the radiations that must pass through them to reach tumor tissues.